
Gliclazide(Glikant)60mg
₱15.00Add to cartGliclazide(Glikant) is a medication used to help manage specific health conditions as prescribed by a healthcare professional.

Gliclazide(Glycinorm-80) 80mg
₱6.00Add to cartGliclazide(Glycinorm-80) is a medication used to help manage specific health conditions as prescribed by a healthcare professional.

Gliclazide(Mediclazide)60mg
₱15.00Add to cartGliclazide(Mediclazide) is a medication used to help manage specific health conditions as prescribed by a healthcare professional.

Gliclazide(Neoclazz MR)60mg
₱10.50Add to cartGliclazide(Neoclazz MR) is a medication used to help manage specific health conditions as prescribed by a healthcare professional.

Gliclazide(Zebet-80) 80mg
₱6.00Add to cartGliclazide(Zebet-80) is a medication used to help manage specific health conditions as prescribed by a healthcare professional.

Glimepiride (Diabeats) 2mg
₱7.00Add to cartGlimepiride (Diabeats) is a medication used to help manage specific health conditions as prescribed by a healthcare professional.

Glimepiride (Diabeats) 4mg
₱15.00Add to cartGlimepiride (Diabeats) is a medication used to help manage specific health conditions as prescribed by a healthcare professional.

Glimepiride (Dianov) 2mg
₱7.00Add to cartGlimepiride (Dianov) is a medication used to help manage specific health conditions as prescribed by a healthcare professional.

Glimepiride (Retaglim) 2mg
₱7.00Add to cartGlimepiride (Retaglim) is a medication used to help manage specific health conditions as prescribed by a healthcare professional.

Glimepiride 2mg(Amara)
₱11.00Add to cartGlimepiride is a medication used to help manage specific health conditions as prescribed by a healthcare professional.

Glimepiride 3mg (Diabeats)
₱9.00Add to cartGlimepiride is a medication used to help manage specific health conditions as prescribed by a healthcare professional.

Glimepiride 4mg( Amara)
₱15.25Add to cartGlimepiride is a medication used to help manage specific health conditions as prescribed by a healthcare professional.
